Related Experiment Video
Updated: Feb 12, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Prognostic Value of Blood Panel Parameters in Patients With Dilated Cardiomyopathy and Advanced Heart Failure
J M Sobrino-Márquez1, A Grande-Trillo1, E M Cantero-Pérez1
1Heart Failure and Heart Transplant Unit, Department of Cardiology, Hospital Universitario Virgen del Rocío, Seville, Spain.
Insights
Basic blood tests can predict outcomes in patients with dilated cardiomyopathy (DCM) and heart failure. A higher red cell distribution width (RDW) indicates increased risk of mortality or heart transplant, aiding in patient stratification.
Area of Science:
- Cardiology
- Hematology
- Biomarkers
Background:
- Dilated cardiomyopathy (DCM) and left ventricular dysfunction present varied clinical courses.
- Prognostic markers are crucial for stratifying patients with heart failure.
- Left ventricular ejection fraction (LVEF) and symptoms alone do not fully predict outcomes.
Purpose of the Study:
- To determine the prognostic value of basic blood panel parameters in patients with DCM and severe left ventricular dysfunction.
- To identify simple blood markers for risk stratification in heart failure patients.
Main Methods:
- Analysis of 87 patients with idiopathic or familial DCM and LVEF <30% from 2009-2011.
- 5-year follow-up data to assess mortality and heart transplant events.
- Evaluation of red cell distribution width (RDW) and neutrophil to lymphocyte ratio (NLR).
Main Results:
- Patients with better outcomes had lower RDW, higher lymphocyte counts, and lower NLR.
- An RDW ≥15% was significantly associated with increased long-term mortality or need for heart transplant.
- No significant differences in age or sex between survival and non-survival groups.
Conclusions:
- Basic blood panel parameters, particularly RDW, can serve as useful prognostic tools for heart failure patients.
- A multimarker strategy may enhance patient stratification in advanced heart failure.
- Larger studies are needed to validate these findings.
Background:
Patients with dilated cardiomyopathy (DCM) and left ventricular dysfunction have a varied clinical course, not only dependent on left ventricular ejection fraction (LVEF) and symptoms. Finding prognostic markers for stratification in these 2 conditions is a critical area of research. Our aim was determine the prognostic value of blood panel basic parameters.
Methods:
We analyzed all patients with idiopathic or familial DCM and LVEF <30% coming to our heart failure unit for evaluation for non-urgent heart transplant during the period of 2009 to 2011. With 5 years of follow-up data, we could study the prognostic value of blood panel parameters. Moreover, we determined the combination of platelet count and neutrophil to lymphocyte ratio score from the BIOSTAT-CHF study.
Results:
Eighty-seven patients were included in the study. After 5 years follow-up, 49 patients (57%) remain alive (group A) and 38 (43%) either died or needed a heart transplant. There were no differences between groups with regard to age or sex. Patients with good progress showed a lower red cell distribution width (RDW), a higher lymphocyte count, and a lower neutrophil/lymphocyte ratio in the initial blood panel. An RDW ≥15% was associated with long-term mortality or heart transplant.
Conclusion:
A basic blood panel could be a useful tool in assessing patients with heart failure. Larger studies are necessary to confirm our findings. A multimarker strategy could also be useful for stratification of patients with advanced heart failure.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Diuretics